Carnitine-acylcarnitine translocase deficiency (CACTD), a fatty acid oxidation defect (FAOD), can present in the neonatal period with non-specific findings and hypoglycemia. This evidence concerns the gene SLC25A20 and carnitine-acylcarnitine translocase deficiency.